PERKINELMER INC (PKI)
US7140461093 - Common Stock
We assign a fundamental rating of 5 out of 10 to PKI. PKI was compared to 58 industry peers in the Life Sciences Tools & Services industry. While PKI belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. PKI has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
PKI had positive earnings in the past year.
PKI had a positive operating cash flow in the past year.
PKI had positive earnings in each of the past 5 years.
In the past 5 years PKI always reported a positive cash flow from operatings.
1.2 Ratios
PKI has a better Return On Assets (5.28%) than 76.19% of its industry peers.
PKI's Return On Equity of 10.11% is fine compared to the rest of the industry. PKI outperforms 77.78% of its industry peers.
PKI has a better Return On Invested Capital (6.49%) than 73.02% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PKI is significantly above the industry average of 9.89%.
The 3 year average ROIC (52.37%) for PKI is well above the current ROIC(6.49%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.28% | ||
| ROE | 10.11% | ||
| ROIC | 6.49% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
1.3 Margins
PKI's Profit Margin of 16.32% is amongst the best of the industry. PKI outperforms 82.54% of its industry peers.
PKI's Profit Margin has improved in the last couple of years.
PKI's Operating Margin of 23.43% is amongst the best of the industry. PKI outperforms 88.89% of its industry peers.
PKI's Operating Margin has improved in the last couple of years.
PKI has a Gross Margin of 58.39%. This is in the better half of the industry: PKI outperforms 76.19% of its industry peers.
PKI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.43% | ||
| PM (TTM) | 16.32% | ||
| GM | 58.39% |
OM growth 3Y19.66%
OM growth 5Y11.6%
PM growth 3Y29.61%
PM growth 5Y5.8%
GM growth 3Y7.46%
GM growth 5Y4.78%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so PKI is creating value.
Compared to 1 year ago, PKI has about the same amount of shares outstanding.
PKI has more shares outstanding than it did 5 years ago.
PKI has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.51 indicates that PKI is not a great score, but indicates only limited risk for bankruptcy at the moment.
PKI's Altman-Z score of 2.51 is in line compared to the rest of the industry. PKI outperforms 55.56% of its industry peers.
PKI has a debt to FCF ratio of 7.40. This is a slightly negative value and a sign of low solvency as PKI would need 7.40 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.40, PKI is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
PKI has a Debt/Equity ratio of 0.53. This is a neutral value indicating PKI is somewhat dependend on debt financing.
PKI's Debt to Equity ratio of 0.53 is on the low side compared to the rest of the industry. PKI is outperformed by 68.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 7.4 | ||
| Altman-Z | 2.51 |
ROIC/WACC0.65
WACC10.02%
2.3 Liquidity
A Current Ratio of 2.13 indicates that PKI has no problem at all paying its short term obligations.
PKI has a worse Current ratio (2.13) than 68.25% of its industry peers.
A Quick Ratio of 1.87 indicates that PKI should not have too much problems paying its short term obligations.
PKI has a Quick ratio of 1.87. This is in the lower half of the industry: PKI underperforms 65.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.13 | ||
| Quick Ratio | 1.87 |
3. Growth
3.1 Past
PKI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.47%.
Measured over the past years, PKI shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.15% on average per year.
The Revenue has decreased by -3.37% in the past year.
PKI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.97% yearly.
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y22.15%
EPS growth Q2Q-33.59%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y7.97%
Revenue growth Q2Q-27.89%
3.2 Future
The Earnings Per Share is expected to grow by 6.04% on average over the next years.
Based on estimates for the next years, PKI will show a decrease in Revenue. The Revenue will decrease by -8.60% on average per year.
EPS Next Y-34.36%
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
EPS Next 5Y6.04%
Revenue Next Year-31.32%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.6%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 14.51, PKI is valued correctly.
Based on the Price/Earnings ratio, PKI is valued cheaper than 96.83% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.06. PKI is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 22.11, PKI is valued on the expensive side.
Based on the Price/Forward Earnings ratio, PKI is valued a bit cheaper than 77.78% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.72. PKI is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.51 | ||
| Fwd PE | 22.11 |
4.2 Price Multiples
PKI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PKI is cheaper than 93.65% of the companies in the same industry.
87.30% of the companies in the same industry are more expensive than PKI, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.52 | ||
| EV/EBITDA | 12.35 |
4.3 Compensation for Growth
PKI has an outstanding profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as PKI's earnings are expected to decrease with -4.57% in the coming years.
PEG (NY)N/A
PEG (5Y)0.66
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
5. Dividend
5.1 Amount
PKI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
PERKINELMER INC
NYSE:PKI (5/15/2023, 7:04:00 PM)
After market: 115.24 0 (0%)115.24
-1.06 (-0.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap14.57B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.51 | ||
| Fwd PE | 22.11 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.28% | ||
| ROE | 10.11% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 23.43% | ||
| PM (TTM) | 16.32% | ||
| GM | 58.39% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.13 | ||
| Quick Ratio | 1.87 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y
EPS growth Q2Q
EPS Next Y-34.36%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y